5HTT reuptake/5HT2C receptor inhibitors (Angita)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5HTT reuptake/5HT2C receptor inhibitors (Angita)
Drug Alias Name5HTT reuptake/5HT2C receptor inhibitors (Angita)5HTT reuptake/5HT2C receptor inhibitors (Angita)AG-0387
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2c (5-HT2c) receptor antagonistsSerotonin reuptake inhibitors
TargetsSerotonin 2c (5-HT2c) receptorSerotonin transporter
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngita Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAngita Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A